Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
NCT06088732 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-05-23
Summary
This is a 2x2, within-subjects, cross-over trial to test the anti-depressant effects of acute exercise in 20 participants with bipolar depression. Participants will complete four experimental sessions, two with an exercise challenge and two with a resting control condition in a counterbalanced order. Participants will receive either 800mg of ibuprofen or placebo before exercise or rest in order to test whether blocking the inflammatory response to exercise interferes with the neural and psychological effects of exercise.
Conditions
Interventions
- OTHER
-
Exercise Session
30 min cycling on bicycle ergometer at 60% peak power output
- DRUG
-
Ibuprofen 800 mg
A single oral dose of Ibuprofen
- OTHER
-
Rest
Resting for 30 min in chair
- DRUG
-
Matched placebo
Sponsors & Collaborators
-
Laureate Institute for Brain Research, Inc.
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-12
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
NCT01403662 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
NCT03349528 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
NCT02989727 ·Status: COMPLETED ·Phase: PHASE4
-
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
NCT01797575 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
NCT06429722 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History of Depression, Bipolar Disorder and Suicide Risk
NCT06462196 ·Status: RECRUITING
-
Toward Exercise as Medicine for Adolescents With Bipolar Disorder
NCT03562520 ·Status: TERMINATED ·Phase: NA
-
The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression
NCT02155972 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase III Study of SM-13496 in Patients With Bipolar I Depression.
NCT01986101 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)
NCT06273774 ·Status: COMPLETED ·Phase: PHASE1
-
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
NCT00188942 ·Status: COMPLETED ·Phase: PHASE4
-
Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
NCT00457054 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
NCT01390389 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
NCT07108257 ·Status: RECRUITING ·Phase: NA
-
Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder
NCT06605599 ·Status: COMPLETED ·Phase: PHASE2
-
An Innovative Master Platform for Clinical Trials in Mood Disorders
NCT06408012 ·Status: RECRUITING
-
Treatment Study of Bipolar Depression
NCT00947791 ·Status: TERMINATED ·Phase: PHASE4
-
Interval Training in Bipolar Disorder
NCT02498730 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).
NCT05227209 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
NCT05169710 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
NCT00812058 ·Status: COMPLETED ·Phase: PHASE2
-
Minocycline for Bipolar Depression
NCT01514422 ·Status: COMPLETED ·Phase: PHASE4
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
NCT06226025 ·Status: RECRUITING ·Phase: PHASE2
-
Scopolamine in Bipolar Depression
NCT04211961 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder
NCT05762887 ·Status: COMPLETED ·Phase: NA